GlassScriptPhysician profile
Amanda D White
NPI 1730452012
$87,939.18
in general payments reported to CMS, 2019-2025
30 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16K · 2022: $26K · 2023: $15K · 2024: $18K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Food and Beverage: $8,017 · Travel and Lodging: $2,536 · Education: $93.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,536.00 |
| Food and Beverage | $8,017.37 |
| Travel and Lodging | $2,535.77 |
| Education | $93.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $81,357.20 | 2021-2025 | Interstim, Intellis Adaptivestim, Altaviva |
| Axonics, INC. | $1,297.54 | 2023-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $870.65 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $840.99 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $375.84 | 2021-2023 | |
| Boston Scientific Corporation | $290.54 | 2024-2025 | Ams 700, Rezum Generator, Spaceoar Vue System - 10ml |
| Merck Sharp & Dohme LLC | $288.87 | 2022-2024 | Lynparza, Keytruda |
| Teleflex LLC | $262.13 | 2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $248.66 | 2022-2023 | Prolaris |
| Abbvie INC. | $218.03 | 2022-2025 | |
| Antares Pharma, INC. | $211.67 | 2022-2023 | Xyosted |
| Procept Biorobotics Corporation | $207.95 | 2025 | |
| Bluewind Medical | $205.31 | 2024-2025 | Revi |
| Bayer Healthcare Pharmaceuticals INC. | $184.11 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $159.11 | 2024 | Adstiladrin |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avation Medical, INC. | $136.32 | 2024 | Vivally |
| Myovant Sciences INC. | $131.56 | 2021-2022 | |
| Endo USA, INC. | $130.00 | 2024 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $129.17 | 2021-2024 | Provenge |
| Blue Earth Diagnostics | $102.88 | 2021-2022 | |
| Olympus America INC. | $61.60 | 2024 | Itind System |
| Urogen Pharma, INC. | $54.33 | 2021-2022 | |
| Genzyme Corporation | $39.52 | 2022-2023 | |
| Angiodynamics, INC. | $28.77 | 2023 | Nanoknife |
| Valencia Technologies Corporation | $24.16 | 2023 | Ecoin Device Kit |
| Coloplast Corp | $22.87 | 2023 | Altis |
| C. R. Bard, INC. & Subsidiaries | $16.97 | 2021 | |
| Pfizer INC. | $16.70 | 2022 | |
| Urovant Sciences INC | $13.83 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.